Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)

Published:2015-09 Issue:14 Volume:51 Page:1927-1936
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Heinemann Volker,Stintzing Sebastian^ORCID,Modest Dominik P.,Giessen-Jung Clemens,Michl Marlies,Mansmann Ulrich R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Global cancer statistics (vol. 61, p. 69, 2011);Jemal;Cancer J Clin,2011

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

3. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel;Nordlinger;Ann Oncol,2009

4. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment;Van Cutsem;Ann Oncol,2010

5. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making;Schmoll;Ann Oncol,2012

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis;ESMO Gastrointestinal Oncology;2024-09

2. The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial;Clinical Breast Cancer;2024-07

3. Expression characteristics of tumors as prognostic and predictive markers for resectable and locally advanced colorectal cancer;Russian Journal of Biotherapy;2024-06-26

4. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial;PLOS Medicine;2024-05-10

5. Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study;Journal of Clinical Oncology;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3